The November 2024 Oncology Coding Break, led by Patricia Fordham, focused on refining the accuracy of treatment coding for specific malignancies and conditions. Patricia, a Quality Control Manager at Registry Partners, drew upon her extensive experience conducting abstracting quality reviews to highlight common issues and best practices.
This session centered on three key areas:
- Thyroid Malignancy
- Explored proper treatment coding and how to align it with the correct class of case.
- Essential Thrombocythemia (ET)
- Addressed nuances in identifying and coding treatments categorized as “Other Treatment.”
- Polycythemia Vera (PV)
- Provided insights into coding complex treatment approaches for this condition.
By focusing on these cases, Patricia underscored the importance of precise treatment data for maintaining registry integrity and supporting accurate clinical research outcomes.
For more insights, catch up on the session through the Registry Partners YouTube channel or you can download the presentation as a PDF.
